Biodesix

  • Home
  • Contact us
  • Investors
  • Terms & Conditions
  • Careers
  • About Us
    • Overview
    • Leadership Team
    • Board of Directors
  • Technology
    • Overview
    • ProTS in Depth
    • Technical Papers
  • Products
    • Overview
    • VeriStrat
    • CLIA Laboratory
  • Companion Dx
    • Overview
    • Bio/Pharma Collaboration
    • Case Study
  • Collaboration
    • Overview
    • Clinical Investigators
    • Academic Collaboration
    • Clinical Papers
  • News
    • Press Releases
    • In the News
    • Events
    • Press Releases
    • In the News
    • Events

    Archives

    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
  • Data

    • Clinical Publications
    • Technical Publications
  • Putting Lung Cancer in the Bullseye (Breakthroughs)
    September 25th, 2012
    Biodesix Feels the Buzz at BIO2012 (FierceBiomarkers)
    July 26th, 2012
    Charting a Course for Progress Institute of Medicine report calls for rigor and standardization (The Burrill Report)
    July 10th, 2012
    A Test to Go With It (GenomeWeb)
    July 10th, 2012
    A Better Route for Diagnostics? (Drug Discovery & Development)
    June 12th, 2012
    Advances in Personalized Medicine for Lung Cancer (Science Daily)
    May 22nd, 2012
    Protein Test Found to Boost NSCLC Survival, Costs (MedPage Today)
    January 16th, 2012
    Trial Shows Biodesix Assay Predicts Breast Cancer Response to Femara (Genetic Engineering News)
    December 13th, 2011
    Serum Profiling Making Mark on Predictive Medicine (Genetic Engineering News)
    April 4th, 2011
    Getting Personal (Clinical Lab Products)
    March 2nd, 2011
    « Older Entries

    Copyright 2011 Biodesix, All rights reserved